Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The smell of mary jane is all consuming.
Doesn't seem like there were any R/Ss since that 2007 A/S increase:
http://www.otcmarkets.com/stock/CWIR/company-info
Utah charges for corporate filings, but there is nothing on there that would indicate this # has changed.
Assuming the O/S is about equal to the A/S, there hasn't been nearly enough volume since 2007 to have sold all of those shares before it went zero bid. Fully diluted market cap at today's close is $40million.
IMO, the company or their financiers are still holding about 12-15Billion shares into this dream come true.
ASCM was the ax today.
CWIN - 20BILLION A/S
Quote:
(1) To increase the authorized shares of Common Stock to twenty billion (20,000,000,000);
and
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=5242018
ROTF. CWIR has 20BILLION shares A/S alone. HFBG another 7B.
(1) To increase the authorized shares of Common Stock to twenty billion (20,000,000,000);
and
Not short. Not long. Just LeGoosin' my way along, with one eye in each direction watching for the hatchet.
LeGler's money smells the same as the rest.
Your LeMoney is as good as the others.
FF,
Yes, I agree with you, this is a scam stock playing the MJ train like all others. Trade it. Don't marry it. Make sure you're not the one holding the bag when the house of cards folds.
You've got to pump it, before you dump it.
You've got to tap it, before you smack it.
Ahh - that's right. It was the global lock on this pig. Thanks.
Not sure if this was previously announced, but they also did a name change with the SOS on Friday:
Filing Name Changed From: VEGA BIOFUELS, INC. To: Biotech Energy Corporation
Sounds like you can add CWIR to that list as well.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=96339442
It looks like they're planning a R/S?
A/S went from 950mm to 95k on Friday. Just guessing, but maybe a 1 for 1000 on the A/S and a 1 for 2000 on the commons?
https://wyobiz.wy.gov/Business/FilingDetails.aspx?eFNum=179173029064177221049057084014233053213213057223
Wasn't HFBG suspended by the SEC awhile back?
CytoSorbents Retains Merriman Capital as Capital Markets Advisor
http://online.wsj.com/article/HUG1752994.html
SAN FRANCISCO - January 7, 2014 - Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), is pleased to announce that it has been retained as Capital Markets Advisor to CytoSorbents Corporation ("the Company") (OTCQB: CTSO).
Merriman will provide CytoSorbents with strategic advice on the effective engagement of a broader institutional shareholder base, financing solutions, corporate brokerage services and strategies for organizing their capital structure. Merriman's Capital Markets Advisory Group clients also benefit from access to unique capital solutions and the implementation of various public markets initiatives.
CytoSorbents is an emerging critical care immunotherapy company that targets the prevention or treatment of organ failure due to inflammation in critically ill patients through the use of proprietary blood purification processes. The Company's patented technology, CytoSorb®, controls the "cytokine storm" that can lead to excessive inflammation and the failure of vital organs such as the heart, lungs, and kidneys. Organ failure causes nearly half of all deaths in the intensive care unit and has no effective treatment options. This extracorporeal cytokine filter contains porous polymer beads that act like sponges to remove harmful substances from blood and is approved in the European Union for use in any situation where cytokines are elevated in a patient. CytoSorbents is headquartered in Monmouth Junction, New Jersey, with direct sales in Germany, Austria and Switzerland, and distributors in the United Kingdom, Ireland, the Netherlands, Russia, and Turkey, as well as a strategic partnership with Biocon Ltd, India's largest biotechnology company, in India.
"I am pleased to announce CytoSorbents as a new addition to our family of Capital Markets Advisory clients," commented Douglas Rogers, Managing Director and Head of the Capital Markets Advisory Group at Merriman. Doug continued, "CytoSorbents has what we believe to be high potential for growth with innovative and proven technology, an excellent management team and a robust pipeline of strategic opportunities. The Capital Markets Advisory Group will offer CytoSorbents' management team with a range of services including market insight, corporate brokerage services as well as strategic advice and access to capital solutions."
About Merriman Capital, Inc.
Merriman Capital, Inc. is a full service investment bank and Broker-Dealer that facilitates efficient capital formation through a proprietary digital network, as well as Capital Markets Advisory and comprehensive Corporate Brokerage services for public and private companies. The firm also provides equity and options execution services for sophisticated investors and differentiated research for high growth companies. Merriman Capital, Inc. is a wholly owned brokerage subsidiary of Merriman Holdings, Inc. (OTCQX: MERR) and is the leading advisory firm for publicly traded, high-growth companies.
Digital Capital Network, powered by Merriman Capital, is a capital marketplace that enables highly targeted and more efficient execution of transactions. Please visit our website for more information on how you can be a part of our Digital Capital Network: http://www.digitalcapitalnetwork.com
Merriman Capital, Inc. is a registered broker-dealer and member of The Financial Industry Regulatory Authority (FINRA) http://www.finra.org/ and the Securities Investor Protection Corporation (SIPC) http://www.sipc.org/.
About CytoSorbents Corporation
CytoSorbents is a critical care immunotherapy company using blood purification to modulate inflammation -- with the goal of preventing or treating multiple organ failure in life-threatening illnesses. Organ failure is the cause of nearly half of all deaths in the intensive care unit, with little to improve clinical outcome. CytoSorb®, the Company's flagship product, is approved in the European Union as a safe and effective extracorporeal cytokine filter, designed to reduce the "cytokine storm" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, and pancreatitis. These are conditions where the mortality is extremely high, yet no effective treatments exist. CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbents has numerous products under development based upon this unique blood purification technology, protected by 32 issued US patents and multiple applications pending, including HemoDefend(TM), ContrastSorb, DrugSorb, and others. Additional information is available for download on the Company's website: http://www.cytosorbents.com
CTSO getting a lot of visibility
SUTI
A/S raised from 2.5BILLION to 4.5BILLION today
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=3qx4hm2n442ri3%252fWAZJXGA%253d%253d&CorpName=SUTIMCO+INTERNATIONAL%2c+INC.
NEWS OUT AFTER HOURS TODAY!
A/S raised from 2.5BILLION to 4.5BILLION today!
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=3qx4hm2n442ri3%252fWAZJXGA%253d%253d&CorpName=SUTIMCO+INTERNATIONAL%2c+INC.
If I was still holding shares I would have them on the ask at .0002 right now. If they weren't filled, I would hit the bid before EOD today.
You need to make sure that you're out of this by EOD.
Wow
1 for 2 R/S on the A/S
1 for 1000 R/S on the commons
How there's still a bid today is beyond me.
Way off on your AFPW 1.5B A/S guess. Good call on figuring out this perpetual scam early on.
Today 3.5 BILLION
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=oNJGwmSnPW%252bNtR%252fKcke85Q%253d%253d&CorpName=ALUMIFUEL+POWER+CORPORATION
You're kind of right. There may be news, but it will be to dump billions of shares into before the next R/S.
It's the SOS that governs the A/S, not the T/A.
750million to 3.5BILLION
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=oNJGwmSnPW%252bNtR%252fKcke85Q%253d%253d&CorpName=ALUMIFUEL+POWER+CORPORATION
Listen, I know how good my coffee is. I buy it.
AFPW
750million to 3.5BILLION upped today
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=oNJGwmSnPW%252bNtR%252fKcke85Q%253d%253d&CorpName=ALUMIFUEL+POWER+CORPORATION
That's a pretty big A/S increase today:
750million to 3.5BILLION
http://nvsos.gov/sosentitysearch/corpActions.aspx?lx8nvq=oNJGwmSnPW%252bNtR%252fKcke85Q%253d%253d&CorpName=ALUMIFUEL+POWER+CORPORATION
Trying to scare people on the ask - accumulating on the bid
Anyway, here comes the break of .0007
Float is tight now - I would imagine we break yesterday's high of .0009
Nice action today. Looks like it could be a quick shot to .50
Here comes the break!
Nice move here today! If people keep to the ask we should hit .00s
Can I get an Amen? ;)
The 24month low was .0018
35% = .0006
$450K/.0006 = 750,000,000 shares that will be coming to market
Zacks reaffirms CTSO "outperform" rating with a .50 price target:
http://zolmax.com/investing/cytosorbentss-outperform-rating-reaffirmed-at-zacks-ctso/192225/
I don't see Shefte's name mentioned anywhere in any of the recent publications about the Bolt the case...?
When did Shefte and Bolt have an affiliation?
Confucius say, man who walk through airport turn-style sideways is going to Bangkok
Holy dump-a-thon - only about 1.5BILLION shares left for them to sell.
Thanks for the update Sky.
It appears that FINRA is telling BMA that their final decision process might be made much easier on the back of a Form 10 filing.
This seems to be in-line with the SEC's efforts to clean up the pinks and move companies towards being fully reporting.
I am a bit disappointed that FINRA has been dragging their feet for so long, perhaps with good reason, but at least they're communicating.
In the end, we could end up with MIKP being a fully reporting, audited, OTCQB stock. Or not, lol.
Decent volume today. May have to pick up a few in the AM.